肝癌器官的药物-蛋白质基因特征用于精确瘤学
Shuyi Ji1,2, Li Feng3, Zile Fu2
1Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai 201508, China.
Science translational medicine
|July 26, 2023
概括
来自患者的肝癌器官揭示了与预后和药物反应相关的亚型. 这种药物-蛋白质基因资源通过确定肝癌的向疗法和药物组合来帮助精准医学.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 蛋白质组学是指蛋白质组学.
背景情况:
- 器官模型可以模仿瘤生物学和药物反应.
- 肝癌精度治疗的综合性药理蛋白学和生物标志物发现有限.
研究的目的:
- 为了建立一个患者衍生肝癌有机生物库 (LICOB) 用于多组学分析.
- 调查药物反应特征并确定精确肝癌治疗的生物标志物.
主要方法:
- 建立了一个来自患者的肝癌有机生物库 (LICOB).
- 进行了多基因组分析 (基因组,表观基因组,转录基因组,蛋白质基因组).
- 进行高通量药物查和综合性药物-蛋白质基因组分析.
主要成果:
- 蛋白质基因组分析确定了与患者预后相关的增殖性和代谢性有机体亚型.
- 鲜明的药物反应模式与多组学特征相关.
- 鉴定了与药物反应相关的分子特征,并预测了协同作用的药物组合 (例如,西罗和伦瓦提尼布).
结论:
- LICOB是了解肝癌生物学和药物依赖的宝贵资源.
- 综合性分析能够预测肝癌的个性化治疗策略.
- 这项研究支持功能精准医学在肝癌中的进步.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...


